Zealand Pharma and OTR Therapeutics Seal $2.5 Billion Metabolic Disease Partnership
OTR Therapeutics announced a strategic collaboration and licensing agreement with Zealand Pharma A/S (NASDAQ: ZEAL)...
OTR Therapeutics
OTR Therapeutics Series-A Raises $100M for Neurology Pipeline
OTR Therapeutics Limited announced the successful completion of a USD 100 million Series A financing,...